AG8 Stock Overview
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for AG8 from our risk checks.
Agilent Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$120.20 |
| 52 Week High | US$141.70 |
| 52 Week Low | US$103.05 |
| Beta | 1.07 |
| 11 Month Change | -4.75% |
| 3 Month Change | -4.89% |
| 1 Year Change | 16.02% |
| 33 Year Change | -17.76% |
| 5 Year Change | 65.68% |
| Change since IPO | 462.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| AG8 | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | -5.6% | -7.0% | -1.5% |
| 1Y | 16.0% | 1.3% | 7.9% |
Return vs Industry: AG8 exceeded the German Life Sciences industry which returned 2.8% over the past year.
Return vs Market: AG8 exceeded the German Market which returned 8.3% over the past year.
Price Volatility
| AG8 volatility | |
|---|---|
| AG8 Average Weekly Movement | 3.9% |
| Life Sciences Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: AG8 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: AG8's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 17,400 | Padraig McDonnell | www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Agilent Technologies, Inc. Fundamentals Summary
| AG8 fundamental statistics | |
|---|---|
| Market cap | €34.68b |
| Earnings (TTM) | €1.34b |
| Revenue (TTM) | €6.17b |
25.8x
P/E Ratio5.6x
P/S RatioIs AG8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AG8 income statement (TTM) | |
|---|---|
| Revenue | US$6.50b |
| Cost of Revenue | US$2.96b |
| Gross Profit | US$3.53b |
| Other Expenses | US$2.12b |
| Earnings | US$1.41b |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | 4.92 |
| Gross Margin | 54.39% |
| Net Profit Margin | 21.75% |
| Debt/Equity Ratio | 49.7% |
How did AG8 perform over the long term?
See historical performance and comparison